Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS, MISCELLANEOUS

Patient Choice Announces New Partnerships with Medical Licensed Producers - Dykstra Greenhouses, Lupos Biotechnology, and Parkland Flower.


Toronto, March 03, 2021 (GLOBE NEWSWIRE) -- Patient Choice is a one-stop-shop that gives registered medical cannabis patients across Canada flexible and convenient freedom to purchase their medicine from a range of different providers. Their goal is to provide convenient access to a broad variety of high-quality and fairly priced medical cannabis. They have partnered with robust and trusted producers of high-quality medical cannabis.

"Partnering with trusted licensed producers increases our continuing effort to offer our patients superior medical cannabis products," says Andrew Richard, Co-Founder & Chief Operations Officer of Patient Choice.

" Partnering with Patient Choice allows us to focus on growing superior products instead of worrying about administration - it is a dream partnership where everyone benefits," says Larry Dykstra, Dykstra Greenhouses.

Patient Choice has partnered with Dykstra Greenhouses, Lupos Biotechnology, and Parkland Flower, federally Licensed Producers and Processors, to  bring top-quality medical cannabis products to Patient Choice consumers.  

"Our goal is to have easy access of our clones and seeds to patients, and with Patient Choice, we can accomplish this goal," adds Kieley Beaudry, Parkland Flower.

Patient Choice operates on a non-possession model, which means they don't hold inventory. Products are delivered fresh and direct from producers to patients. That approach allows patients to have access to a wide range of quality products, not just products from one licensed producer or those that sell a lot of volume. 

"This is a great opportunity for us to join a trusted medical platform to offer Proofly topical products to Canadian patients through Patient Choice," adds John King, CEO, Lupos Biotech.

Patient Choice continues to diversify their offering with a robust and trusted selection of producers of high-quality medical cannabis. With a trustworthy, licensed, and compliant medical platform, producers can highlight & sell their products to a large and ever-increasing group of Canadian patients; patients who use the Patient Choice platform because they trust to be connected to high-quality medical cannabis.


For more information visit Patient Choice website. 



ABOUT Patient Choice:

Patient Choice is here to redefine the way patients receive and access medical cannabis.Our goal is to provide you with convenient access to a broad variety of high-quality and fairly priced medical cannabis products to support your health and wellness goals. Patient Choice is brought to you by Empress Agri Sales Inc, a Health Canada Medical Sales License holder under the Cannabis Act. We're passionate about leading the charge to create a fair and equitable new ecosystem that protects patients and supports craft producers.



MEDIA INQUIRIES:

Amanda Lockington, Account Executive at amanda@marigoldpr.com or 1-877-681-5541.




Contact Lupos (Canada) Biotechnology Inc. 1 (855) 554-1217 info@lupos.ca

Contact Dykstra Greenhouses 905-932-2812 1422206ontarioinc@gmail.com

Contact Parkland Flower 780.266.9996



These press releases may also interest you

at 20:07
On October 5, 2020, Beacon Health Solutions, LLC ("Beacon") experienced a data security incident that prevented users from accessing systems and data. Upon discovering this incident, Beacon immediately launched an investigation and engaged a digital...

at 20:05
Cutera, Inc. ("Cutera" or the "Company"), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced that it will report financial results for the first quarter 2021 after the market close on...

at 20:00
Sysinno Technology Inc., an Innodisk shareholding company, is excited to announce that their iAeris line of indoor air quality detectors will run on Microsoft Azure's Sphere, making them at this time the world's first and only production-stage air...

at 20:00
RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced today execution of definitive agreements for a seed round financing of $10 million. RNAimmune is a spin-off...

at 20:00
Today, nursing homes are the focus of intense scrutiny due to the high number of deaths during the 2020 pandemic. Covid-19 deaths in long-term nursing care facilities make up half of all such deaths in at least 18 states to date. Fears of inadequate...

at 19:56
Canada Economic Development for Quebec Regions Budget 2021 is the Government of Canada's plan to finish the fight against COVID-19 and ensure a robust economic recovery that is inclusive of all Canadians. Today, the Minister of Economic Development...



News published on 3 march 2021 at 06:10 and distributed by: